Convenient synthesis of heteroaryl-linked benzimidazoles via microwave-assisted boronate ester formation

Tetrahedron Letters

Volumn 50, Issue 13, 2009, Pages 1399-1402

  Rheault, Tara R ^a   Donaldson, Kelly H ^a   Cheung, Mui ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; BORONIC ACID DERIVATIVE; ESTER; HALIDE;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; MICROWAVE RADIATION; SUZUKI REACTION; SYNTHESIS;

EID: 59649120554     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.01.087     Document Type: Article

References (20)

1. For examples of benzimidazole-based Raf kinase inhibitors see:. Smith R.A., Dumas J., Adnane L., and Wilhelm S.M. Curr. Top. Med. Chem. 6 (2006) 1071
2. For examples of benzimidazole-based IGF1R kinase inhibitors see:. Velaparthi U., Wittman M., Liu P., Carboni J.M., Lee F.Y., Attar R., Balimane P., Clarke W., Sinz M.W., Hurlburt W., Patel K., Discenza L., Kim S., Gottardis M., Greer A., Li A., Saulnier M., Yang Z., Zimmermann K., Trainor G., and Vyas D. J. Med. Chem. 51 (2008) 5897
3. Hubbard R.D., Bamaung N.Y., Palazzo F., Zhang Q., Kovar P., Osterling D.J., Hu X., Wilsbacher J.L., Johnson E.F., Bouska J., Wang J., Bell R.L., Davidsen S.K., and Sheppard G.S. Bioorg. Med. Chem. Lett. 17 (2007) 5406
4. Lindberg P. Comp. Med. Chem. II 8 (2006) 213
5. Hirashima S., Suzuki T., Ishida T., Noji S., Yata S., Ando I., Komatsu M., Ikeda S., and Hashimoto H. J. Med. Chem. 49 (2006) 4721
6. Lansing T.J., McConnell R.T., Duckett D.R., Spehar G.M., Knick V.B., Hassler D.F., Noro N., Furuta M., Emmitte K.A., Gilmer T.M., Mook Jr. R.A., and Cheung M. Mol. Cancer Ther. 6 (2007) 450
7. For the synthesis of ester and amide substrates 1 see: (a) Hornberger, K. R.; Badiang, J. G.; Salovich, J. M.; Kuntz, K. W.; Emmitte, K. A.; Cheung, M. Tetrahedron Lett. 2008, 49, 6348. (b) Kuntz, K.; Emmitte, K. A.; Rheault, T. R.; Smith, S.; Hornberger, K.; Dickson, H.; Cheung, M. PCT Int. Appl. WO2007143456, 2007.
8. Bilodeau M.T., Cunningham A.M., Koester T.J., Ciecko P.A., Coll K.E., Huckle W.R., Hungate R.W., Kendall R.L., McFall R.C., Mao X., Rutledge R.Z., and Thomas K.A. Bioorg. Med. Chem. Lett. 13 (2003) 2485
9. Liu, H.; Pan, W.; Xu, Y.-J. PCT Int. Appl. WO2005042496, 2005.
10. For an example where the reactivity of the coupling partners is reversed see: Bonjouklian, R.; Dally, R. D.; De Dios, A.; Del Prado Catalina, M. F.; Dominguez-Fernandez, C.; Jaramillo Aguado, C.; Lopez de Uralde-Garmendia, B.; Montero Salgado, C.; Shepherd, T. A. PCT Int. Appl. WO2005080380, 2005.
11. Ishiyama, T.; Chen, H. 4,4,4′,4′,5,5,5′,5′-Octamethyl-2,2′-bi-1,3,2-dioxaborolane. e-EROS Encyclopedia of Reagents for Organic Synthesis, 2001.
12. For examples of microwave-assisted boronate ester formation see:. DiMauro E.F., and Vitullo J.R. J. Org. Chem. 71 (2006) 3959
13. De Borggraeve W.M., Appukkuttan P., Azzam R., Dehaen W., Compernolle F., Van der Eycken E., and Hoornaert G. Synlett (2005) 777
14. Appukkuttan P., Van der Eycken E., and Dehaen W. Synlett (2003) 1204
15. Fürstner A., and Seidel G. Org. Lett. 4 (2002) 541
16. The LC-MS data included in Table 1 were obtained using LC-MS systems calibrated on a daily basis with a system-suitability seven-component test mix to ensure fit for purpose (identity and purity).
17. In addition to unreacted 1, the following by-products were also routinely observed: X = H, 2-12% by LC-MS; unreacted boronic acid, 7-11% by LC-MS; and dimers formed from homocoupling of 1, 0-6% by LC-MS.
18. Fleckenstein C.A., and Plenio H. Chem. Eur. J. 14 (2008) 4267 and references cited therein
19. For examples of pyrazole and imidazole moieties functioning as Pd ligands in Suzuki-Miyaura reactions see:. Mukherjee A., and Sarkar A. Tetrahedron Lett. 45 (2004) 9525
20. Zeng F., and Yu Z. J. Org. Chem. 71 (2006) 5274